Juan Graham - Dec 8, 2022 Form 4 Insider Report for FIBROGEN INC (FGEN)

Role
Chief Financial Officer
Signature
/s/ Cecelia Monoarfa-Taime, Attorney-in-fact
Stock symbol
FGEN
Transactions as of
Dec 8, 2022
Transactions value $
-$85,498
Form type
4
Date filed
12/15/2022, 04:23 PM
Previous filing
Sep 8, 2022
Next filing
Dec 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FGEN Common Stock Sale -$78.1K -5.26K -9.42% $14.84* 50.6K Dec 8, 2022 Direct F1, F2
transaction FGEN Common Stock Sale -$7.39K -478 -0.94% $15.47* 50.2K Dec 8, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a 10b5-1 plan.
F2 These shares were sold in multiple transactions on the reported date with prices ranging from $14.38 to $15.355 resulting in a weighted average price of $14.84. Upon request, the reporting person will provide to the Commission staff or a security holder of the Issuer the number of shares sold and the sale price for each separate transaction.